Compared with older pharmacologic options, GLP-1 receptor agonists and newer incretin-based therapies generally offer greater average weight reduction, but they also raise specific issues related to gastrointestinal tolerability, long-term continuation, affordability, and access ( 6 Safety and practical prescribing considerations in KOA patients Safety considerations are particularly important when GLP-1 receptor agonists are considered for patients with obesity-related KOA, because this population often includes older adults, patients with multimorbidity, and individuals approaching elective arthroplasty
Ingredient line shows plain gelatin or clearly identifies the gelatin source
Retained food during esophagogastroduodenoscopy is a risk factor for gastric-to-pulmonary aspiration
Endocr Connect 2023;12:e220504.ArticlePubMedPMC 4
Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, and Rozen R (1996)
Their effects on the coagulation system, potential interactions, side effects, and warning signs of excessive bleeding underscore the need for moderation and careful medical supervision, especially for individuals taking blood-thinning drugs